- Posts:
- 0 (0 per day)
- Age:
- N/A
- Date Registered:
- May 03, 2024, 12:53:30 PM
- Local Time:
- May 21, 2024, 03:45:42 PM
- Last Active:
- May 03, 2024, 06:18:30 PM
Signature:
Aim To compare the cost-effectiveness of 3 separate regimens-(1) daratumumab, lenalidomide, along with dexamethasone three-way remedy (DRd); (A couple